IKZF1 and cancer: Our work did not analyze survival rates and prognoses owing to the unavailability of clinical data; however, pan-cancer analysis of 14 cancers in TCGA showed that hypermethylated and downregulated MAP4K1, PRKCB, IKZF1, MAP4K1, and SHISA3 were associated with longer overall survival in HNSC and other cancers.